Delivery Order HHSD200201141280I-HHSD2002011412800001
Award Date 9/29/11
Potential Completion Date 9/28/21
Potential Value $5.1M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Gainesville, FL 32611, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
10
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) awarded a $4,679,587.20 Definitive Contract to the Denver Health and Hospital Authority (Denver Health) to develop, implement, and evaluate intervention studies to improve identification of latent tuberculosis infection (LTBI) and treatment-to-cure for high-risk non-U.S.-born populations in primary care settings. This contract, which does not have a set-aside designation, has a period of performance from September 29, 2021 through March 28,...
- This is a $1,353,024.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Denver Health and Hospital Authority, doing business as Denver Health, to harness diverse data through information sciences to improve health outcomes, evaluate bias, recruitment, and retention in an online setting, conduct a recruitment and retention optimization study, and perform content validation of questionnaire modules. The contract supports a pilot study for these...
- This federal contract, valued at $3,752,362.88, was awarded by the Centers for Disease Control and Prevention (CDC) to the University of North Texas Health Science Center at Fort Worth (UNTHSC) to conduct a comparative study on tuberculosis (TB) testing methods. The contract is part of the Tuberculosis Epidemiology Studies Consortium, an indefinite delivery contract, and does not have a set-aside designation. Under this task order, UNTHSC is evaluating the performance of the tuberculin skin test...
- This is a $1,467,579.00 delivery order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health) on September 20, 2019. The contract is titled "IMPROVING THE QUALITY AND REPRESENTATIVENESS OF THE TREATMENT CENTER PROGRAM DATA" and has a completion date of March 15, 2025. The contract is a Firm Fixed Price type with no set-aside designation. It is issued under the FDA...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Denver Health and Hospital Authority, doing business as Denver Health, for $695,889.00. The contract is for data resources to support post-marketing surveillance of nonmedical use of pharmaceuticals and use of illicit drug substances. Denver Health is a comprehensive healthcare system in Denver, Colorado that serves as a provider of medical services, public health programs, and research initiatives for...
- This federal contract award, valued at $630,211.00, was issued by the Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health), a comprehensive healthcare system based in Denver, Colorado. The contract is for understanding the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among the general population through an online panel survey. The contract is a firm-fixed-price delivery order and is not designated as a...
- This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to the Maryland Department of Health Vital Statistics Administration Division, a U.S. state government entity, to support the Tuberculosis Epidemiology Studies Consortium. The contract has a ceiling value of $4,178,577.57 and runs through September 2021. It is a cost-no-fee contract type, with no set-aside designation. The contract provides for a comparison of tuberculin skin tests (TST) versus...
- This firm fixed-price delivery order was awarded to Denver Health and Hospital Authority, doing business as Denver Health, by the Food and Drug Administration (FDA). The $87,552.08 contract is for Denver Health to provide the RADARS StreetRx dataset and RADARS drug diversion services to support the FDA's post-marketing prescription and over-the-counter drug abuse surveillance efforts. This work is being performed under the FDA Prescription Drug Abuse Summary Reports indefinite...
- Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...
- The U.S. Food and Drug Administration (FDA) awarded a Firm Fixed Price definitive contract valued at $307,622.10 to the Denver Health and Hospital Authority, doing business as Denver Health, to evaluate the impact of flow restrictors on pediatric exposures to liquid single-ingredient acetaminophen. This contract was awarded under a Broad Agency Announcement (BAA) solicitation and does not have a set-aside designation. Denver Health is a large healthcare provider and academic medical center...